Advertisement
IYH vs XLV
Which ETF would AI Choose? iShares U.S. Healthcare ETF (IYH) vs. Health Care Select Sector SPDR ETF (XLV)
Key Takeaways
- Both IYH and XLV provide passive exposure to the U.S. healthcare sector through market-capitalization-weighted strategies, yet they track distinct benchmarks that influence diversification and concentration profiles.
- XLV offers significantly lower costs with an expense ratio of 0.08% compared to 0.37% for IYH, enhancing net returns for long-term holders in a sector with moderate dividend yields.
- IYH holds approximately 100 securities drawn from the Russell 1000 Health Care RIC 22.5/45 Capped Index, providing broader representation that includes select mid-cap names, while XLV limits exposure to roughly 60 S&P 500 healthcare constituents.
- Top holdings overlap substantially, led by Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), and AbbVie Inc. (ABBV), though allocation weights differ modestly and drive relative performance in pharmaceutical and biotechnology sub-sectors.
- XLV exhibits tighter liquidity characteristics and lower tracking error potential due to its S&P 500 focus and larger assets under management, making it suitable for institutional and high-volume trading strategies.
- Both funds emphasize large-cap U.S. healthcare companies across pharmaceuticals, biotechnology, and equipment sub-sectors, positioning investors for exposure to aging demographics and innovation cycles without leverage or active management overlays.
Introduction
Investors seeking targeted U.S. healthcare exposure often evaluate IYH and XLV as complementary or alternative vehicles within the same broad sector. These exchange-traded funds (ETFs) do not compete directly as one is not superior in all dimensions; instead, they represent differentiated passive strategies that deliver similar thematic exposure through distinct index methodologies. The comparison highlights trade-offs in cost, breadth, and structural efficiency that matter for portfolio construction amid evolving healthcare innovation and regulatory landscapes.
iShares U.S. Healthcare ETF (IYH) Overview
The iShares U.S. Healthcare ETF (IYH) seeks to track the Russell 1000 Health Care RIC 22.5/45 Capped Index, which measures the performance of U.S. healthcare equities. The fund holds approximately 100 securities and applies market-capitalization weighting with capping constraints to manage concentration. Top holdings typically include Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), UnitedHealth Group Incorporated (UNH), and Merck & Co., Inc. (MRK). Sector allocations concentrate in pharmaceuticals (around 37%), biotechnology (around 23%), and health care equipment (around 15%). The expense ratio stands at 0.37%, reflecting its passive, replication-based structure with quarterly rebalancing aligned to the underlying index methodology.
Health Care Select Sector SPDR ETF (XLV) Overview
The Health Care Select Sector SPDR ETF (XLV) tracks the Health Care Select Sector Index, representing the healthcare component of the S&P 500. It maintains roughly 60 holdings through a market-capitalization-weighted approach and full replication strategy. Leading positions mirror much of the sector but feature Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie Inc. (ABBV), UnitedHealth Group Incorporated (UNH), and Merck & Co., Inc. (MRK) with comparable yet distinct weights. Allocations emphasize pharmaceuticals, biotechnology, and health care providers and services. The expense ratio is 0.08%, underscoring its cost-efficient passive design with low turnover and alignment to S&P 500 index reconstitution cycles.
Industry and Thematic Backdrop
The U.S. healthcare sector encompasses pharmaceuticals, biotechnology, medical equipment, and managed care providers, driven by long-term demographic trends such as population aging and rising chronic disease prevalence. Capital flows into the sector reflect ongoing innovation in areas like GLP-1 therapies, oncology, and precision medicine, alongside periodic regulatory scrutiny on drug pricing and reimbursement policies. Macroeconomic factors, including interest rate environments and broader equity market rotations, influence capital allocation between growth-oriented biotech names and more defensive large-cap pharmaceutical holdings. Sector risks include clinical trial outcomes, patent expirations, and policy changes that can affect earnings visibility across market cycles.
Performance and Positioning Comparison
In recent market cycles, both ETFs have demonstrated correlated movements tied to healthcare earnings seasons and sector rotation dynamics. XLV has benefited from its lower expense ratio and tighter focus on S&P 500 constituents, contributing to marginally higher net efficiency during periods of stable large-cap leadership. IYH offers slightly broader exposure that can capture incremental mid-cap participation within the Russell 1000 framework, potentially enhancing diversification in extended rallies but introducing modest additional volatility. Relative positioning favors XLV for cost-sensitive investors prioritizing liquidity and tracking precision, while IYH suits those seeking marginally expanded holdings within the same thematic universe. Both vehicles exhibit lower beta characteristics relative to the broader market during defensive rotations.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors comparing healthcare sector ETFs can leverage the platform to refine exposure choices aligned with current market conditions.
Tickeron AI Verdict
Tickeron’s AI would currently favor the Health Care Select Sector SPDR ETF (XLV) with moderate probability due to its substantially lower expense ratio, greater liquidity, and efficient replication of the S&P 500 healthcare benchmark, which supports consistent trend capture and lower structural costs over extended holding periods. While IYH provides valuable breadth, the cost and liquidity advantages of XLV align more closely with durable positioning criteria in the current environment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYH is a StrongBuy and XLV is a StrongBuy.
IYH in upward trend: price rose above 50-day moving average on October 09, 2026
IYH moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on IYH as a result. In 69 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for IYH just turned positive on October 12, 2026. Looking at past instances where IYH's MACD turned positive, the stock continued to rise in 40 of 48 cases over the following month. The odds of a continued upward trend are 83%.
The 10-day moving average for IYH crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +4.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYH advanced for three days, in 253 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 201 of 254 cases where IYH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for IYH moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 24 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 73%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
IYH broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
XLV in upward trend: price rose above 50-day moving average on October 09, 2026
XLV moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 39 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on XLV as a result. In 74 of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for XLV just turned positive on October 09, 2026. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
The 10-day moving average for XLV crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +4.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLV advanced for three days, in 265 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 219 of 271 cases where XLV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Bearish Trend Analysis
The 10-day RSI Indicator for XLV moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 29 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
XLV broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| IYH | XLV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 78% |
| Stochastic ODDS (%) | 2 days ago 76% | 2 days ago 79% |
| Momentum ODDS (%) | 2 days ago 78% | 2 days ago 76% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 84% |
| Advances ODDS (%) | 13 days ago 80% | 13 days ago 81% |
| Declines ODDS (%) | 9 days ago 79% | 9 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 77% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 81% |
Advertisement
IYH and
Correlation & Price change
A.I.dvisor indicates that over the last year, IYH has been closely correlated with LLY. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if IYH jumps, then LLY could also see price increases.
XLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, XLV has been closely correlated with LLY. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLV jumps, then LLY could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GAB | 5.15 | 0.04 | +0.78% |
| Gabelli Equity Trust (The) | |||
| AMID | 36.82 | 0.28 | +0.76% |
| Argent Mid Cap ETF (AMID) | |||
| PBP | 23.22 | 0.11 | +0.48% |
| Invesco S&P 500 BuyWrite ETF (PBP) | |||
| FEMD | 34.97 | N/A | N/A |
| First Eagle Mid Cap Equity ETF (FEMD) | |||
| BREM | 48.73 | -0.11 | -0.23% |
| iShares Emerging Markets Bond Active ETF (BREM) | |||